A price target is an analyst’s estimate of what a stock may be worth, based on forecasts and a valuation method. For a health insurer, those forecasts can depend in part on medical costs, premiums, and business mix. A target is a model result—not a promise that the stock will reach that price.
How an analyst turns forecasts into a price target
An analyst estimates future financial performance, chooses a valuation method, and uses it to estimate the value of each share. The forecast and the assumptions matter as much as the final number: two analysts can reach different targets because they expect different earnings or use different valuation inputs.
As an Amazon Associate I earn from qualifying purchases.
Price-to-earnings (P/E)
With a P/E approach, the analyst forecasts earnings per share and applies a valuation multiple. The multiple reflects judgments about factors such as expected growth, risk, business quality, and how comparable companies are valued. CMS defines P/E as share price divided by annual earnings per share and describes it as a tool for comparing managed-care companies. Its comparison covers 1995–2002, so it is historical context—not a current benchmark for valuing an insurer. CMS’s managed-care analysis says the ratio shows what the market is willing to pay for a company’s stock relative to the earnings it generates.
Do these 3 things before closing this tab:
1Fix the driver behind crashes, sound loss and screen glitches2Clear out junk files and repair common Windows errors3Scan for outdated or missing drivers - takes under a minuteDiscounted cash flow (DCF)
A DCF analysis estimates future cash flows and discounts them to present value. Its assumptions can include projected cash flows, the discount rate, terminal value, and how debt is treated when moving from enterprise value to equity value. A 2018 transaction filing describing Cigna’s DCF analysis illustrates these inputs; its figures belong to that historical transaction and should not be treated as current assumptions for a health-insurer stock. The Cigna transaction filing is an example of the mechanics, not a current valuation.
#1 Best Overall
Other methods and combinations
Analysts may use more than one method or select an approach suited to the company. Methods described in a May 21, 2025 Jefferies report about CMS Info Systems—not a health insurer—include DCF; earnings, cash-flow, and EBITDA multiples; peer comparisons; sum-of-the-parts; net asset value; dividends; and return on equity. That report illustrates methodological variety, not health-insurer valuation practice or current peer multiples. The Jefferies report is company-specific.
Why medical loss ratio matters for a health insurer
The medical loss ratio (MLR) is the share of premium revenue spent on clinical services and quality improvement. It gives investors and analysts context for a major part of an insurer’s operations, but it does not translate mechanically into a fixed change in earnings. The effect of a particular MLR change depends on the company’s circumstances and business mix.
Rank #2
CMS says federal rules generally require issuers to spend at least 80% or 85% of premium dollars on medical care, depending on the applicable market, and to pay rebates when they fail to meet the applicable standard. CMS’s MLR explainer describes the requirement and the measure.
MLR figures also have a defined scope. The NAIC explains that the ratio is based on annual aggregate financial allocations by market and state, so a figure for one market or state should not automatically be treated as representative of a diversified insurer’s entire business. The NAIC reports that 2023 rebates, paid in 2024, totaled $947 million for about 6.1 million families—an average of $156 per family. Those are the latest figures stated on its accessed page, not a forecast or a typical amount for an individual insurer. See the NAIC’s MLR consumer information.
S&P Global identifies MLR as a key health-insurer KPI because it indicates the share of premium dollars used for medical care and quality improvement rather than other costs. When reviewing a target, check whether the analyst explains how recent claims experience and the insurer’s business mix inform the earnings or cash-flow forecast. S&P Global’s KPI overview provides this operating context.
How to compare two analysts’ price targets
A target difference is most useful when you can identify which forecast or assumption differs. Compare the underlying work rather than treating the higher number as a standalone signal.
- Forecasts: Note the period covered and the earnings-per-share or cash-flow estimates each analyst uses.
- Valuation method: Check whether each uses P/E, DCF, or another approach, and whether the target combines multiple methods.
- Valuation assumptions: For P/E, compare the selected multiple, peer group, growth expectations, and risk judgments. For DCF, compare projected cash flows, discount rate, terminal value, and debt treatment.
- Insurer operations: Look for clear assumptions about MLR, claims experience, and business mix, and check which markets or business segments the figures cover.
- Timing: Check the report’s publication date and stated time horizon. The sources here do not establish one universal time horizon used by analysts.
A higher target may reflect higher forecast earnings, a more generous valuation multiple, or different assumptions about risk. Without the underlying report and assumptions, the target alone does not reveal which explanation applies.
The Tool Desk
Outbyte Driver Updater FREEFix the driver behind crashes, sound loss and screen glitchesFind Drivers →Outbyte PC Repair FREEClear out junk files and repair common Windows errorsFree Scan →What a price target can—and cannot—tell you
A target summarizes an analyst’s valuation under a particular set of forecasts and assumptions. It can help you understand how the analyst connects expected performance to a share value, especially when the report explains its method and operating assumptions.
It is not a guaranteed future price. The sources cited here do not establish a current target, consensus estimate, or valuation for any particular health insurer. For a stock-specific assessment, use the analyst report’s date and assumptions alongside current company disclosures; do not treat historical examples or a target number without its model as a present-day valuation.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
